Search Results for:
-
IPO Flurry Continues: Receptos Files Proposed $86M Offering
Funds will be used to progress the clinical development program for lead candidate, Pracinostat, its oral histone deacetylase inhibitor for advanced hematologic malignancies, and for other general corporate purposesBy Jennifer Boggs | BioWorld Today | Monday, April 8, 2013 -
Other News To Note
The refund was received to support research and clinical development of PBT2 for Huntington's and Alzheimer's diseases, as well as for other Prana research activities into Parkinson's disease and other neurological indications...Under the terms, Hengrui will fund and lead all preclinical and clinical development, as well as commercialization efforts, in those territories, while X-BODY retains all rights outside Greater ChinaBioWorld Today | Friday, April 5, 2013 -
Vernal Aquinox: Series C Gets $18M to Finish Phase II Trials
The company also disclosed the appointment of Stephen Shrewsbury as senior vice president of clinical development and chief medical officer (CMOBy Randy Osborne | BioWorld Today | Thursday, April 4, 2013 -
Alzheimer's Guidance Shows Challenges Facing FDA, Industry
So far, all clinical development has focused on patients with more advanced forms of the diseaseBio Perspectives | Wednesday, April 3, 2013 -
Synthon to Debut New Focus with HER2-ADC Data at AACR
Lemmens explained that the company's approach here has paralleled that taken in chemical generics, with Synthon undertaking all aspects of research, clinical development, registration and manufacturing, and then signing distributors to market the productsBy Nuala Moran | BioWorld International | Wednesday, April 3, 2013 -
Other News To Note
Proceeds will be used to advance miR-3157 for melanoma through preclinical studies and toward clinical developmentBioWorld International | Wednesday, April 3, 2013 -
Revance Adds $33M for BoNTA Alternative to Botox
The latest round is expected to support ongoing clinical development of lead candidate, LiRIS (lidocaine releasing intravesical system), in development for patients with interstitial cystitis.By Marie Powers | BioWorld Today | Wednesday, April 3, 2013 -
Other News To Note
It will propose a revised clinical development plan in its meeting with the FDABioWorld Today | Wednesday, April 3, 2013 -
Alzheimer's Guidance Shows Challenges Facing FDA, Industry
So far, all clinical development has focused on patients with more advanced forms of the diseaseBy Mari Serebrov | BioWorld Today | Monday, April 1, 2013 -
Appointments and Advancements
Cytos Biotechnology Ltd., of Zurich, Switzerland, appointed Matthias Alder executive vice president for corporate development and legal affairs and named Cheryl Lassen vice president for clinical developmentBioWorld Today | Monday, April 1, 2013 -
Edison Pharma Lands Dainippon in Potential $545M Japan Deal
Pocketing a fistful of cash while retaining development control for most of the world puts Edison "on the threshold of commercialization," with sufficient capital to complete clinical development and initiate commercial activities for EPI-743, he addedBy Marie Powers | BioWorld Today | Friday, March 29, 2013 -
Other News To Note
The work is expected to be completed by the end of 2014 and will focus on ReNeuron's lead CTX stem cell line, which is used in the firm's ReN001 therapy for stroke, which recently entered Phase I development, and ReN009 for critical limp ischemia, due to enter clinical development shortly. (See BioWorld Today, March 28, 2013BioWorld Today | Friday, March 29, 2013 -
Other News To Note
Those funds will be reinvested in further clinical development of the company's lead candidate, EMA401, an AT2 receptor antagonist for the treatment of chronic pain, including neuropathic painBioWorld Today | Thursday, March 28, 2013 -
Vivus Plays for Time; Enters $110M Capped Royalty Deal
Proceeds will be used to advance miR-3157 for melanoma through preclinical studies and toward clinical developmentBy Catherine Shaffer | BioWorld Today | Wednesday, March 27, 2013 -
Other News To Note
iBio Inc., of Newark, Del., added its iBioLaunch-produced recombinant C1 esterase inhibitor to the group of product candidates selected for clinical development by the company and its collaboratorsBioWorld Today | Wednesday, March 27, 2013 -
Financings Roundup
During that period, MedBridge also will provide full administrative support for the company, allowing it to focus on clinical development of the therapeutic pipelineBioWorld Today | Monday, March 25, 2013 -
A 'Moderna' Cinderella Story: AstraZeneca's $240M Up Front
AstraZeneca has the option to pick as many as 40 drug products for clinical development, and Moderna stands to gain milestone payments related to clinical and commercial progress, along with royalties on drug sales ranging from high single digits to low double digits for each productBy Randy Osborne | BioWorld Today | Friday, March 22, 2013 -
Pharma: Other News To Note
Janssen will pay future milestones and royalties and will take the lead on the clinical development of any drugs emerging from the dealBioWorld Today | Thursday, March 21, 2013 -
New Antimalarial Compound Raises Hopes of Eradication
Researchers have developed a new drug that fights the malaria parasite at multiple stages in its life cycle, and in both of its hosts – the human and the mosquito – raising hopes that if the compound makes it through clinical development, it could ultimately hound the parasite out of existenceBy Anette Breindl | BioWorld Today | Thursday, March 21, 2013 -
Helmedix Lands Seed Funding to Back Helminth Peptide R&D
By the end, we hope to have a lead candidate, know the mode of action and be ready to consider clinical development," Thompson told BioWorld InternationalBy Nuala Moran | BioWorld International | Wednesday, March 20, 2013
Category
Current Filters
- xclinical development
Related Keywords
Categories
- x BioWorld Today (3600)
- x BioWorld International (1071)
- x BioWorld Insight (388)
- x Bio Perspectives (111)
- x State of the Industry Report (78)
- x BioWorld Snapshots (32)
- x BioWorld Genomics Review (29)
- x Executive Compensation Report (5)
- x Biotech Innovations (3)
- x RNAi Report (2)
- x Market-Leading Biotech Drugs (2)
- x Top 25 Drug Report (1)
- x Recorded (1)
BioWorld | 3525 Piedmont Road
Building 6, Suite 400 | Atlanta, Georgia 30305, USA
Building 6, Suite 400 | Atlanta, Georgia 30305, USA
Part of Thompson Media Group LLC
Free Ezine
Sign up for Perspectives FREE e-mail newsletter.
Customer Service: In the U.S. and Canada: 1-800-477-6307
Outside the U.S.: 1-404-262-5423
customerservice@bioworld.com
Hours: Monday - Thursday, 8:30 am - 6:00 pm EST
Friday, 8:30am - 4:30 pm EST
Outside the U.S.: 1-404-262-5423
customerservice@bioworld.com
Hours: Monday - Thursday, 8:30 am - 6:00 pm EST
Friday, 8:30am - 4:30 pm EST
Copyright @ 2013 AHC Media. Reproduction, reposting content is strictly prohibited.